NTRK2 and Alzheimer disease: Another study revealed that Srsf3 expression is increased in the hippocampus and temporal cortex of AD patients and suggested that its activity modulates tropomyosin receptor kinase B (TrkB) pre-mRNA splicing to promote neurodegeneration (Wong et al., 2012).